Retrospective analysis of the symptomatic treatment of residual neurological symptoms in Wilson's disease patients

被引：0
|
作者：
Hoelscher, S. [1 ]
Leinweber, B. [1 ]
Hefter, H. [2 ]
Reuner, U. [3 ]
Guenther, P. [4 ]
Weiss, K. [5 ]
Oertel, W. H. [1 ]
Moeller, J. C. [1 ]
机构：
[1] Univ Marburg, Marburg, Germany
[2] Univ Dusseldorf, Dusseldorf, Germany
[3] Tech Univ Dresden, Dresden, Germany
[4] Univ Leipzig, Leipzig, Germany
[5] Univ Heidelberg, D-6900 Heidelberg, Germany
来源：
JOURNAL OF NEURAL TRANSMISSION | 2009年 / 116卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：246 / 246
页数：1
相关论文
共 50 条
  • [1] Evaluation of the Symptomatic Treatment of Residual Neurological Symptoms in Wilson Disease
    Hoelscher, Sara
    Leinweber, Barbara
    Hefter, Harald
    Reuner, Ulrike
    Guenther, Peter
    Weiss, Karl Heinz
    Oertel, Wolfgang H.
    Moeller, Jens Carsten
    EUROPEAN NEUROLOGY, 2010, 64 (02) : 83 - 87
  • [2] Neurological manifestations in Wilson's disease -possible treatment options for symptoms
    Litwin, Tomasz
    Dusek, Petr
    Czlonkowska, Anna
    EXPERT OPINION ON ORPHAN DRUGS, 2016, 4 (07): : 719 - 728
  • [3] Profound midbrain atrophy in patients with Wilson's disease and neurological symptoms?
    Strecker, K.
    Schneider, J. P.
    Barthel, H.
    Hermann, W.
    Wegner, F.
    Wagner, A.
    Schwarz, J.
    Sabri, O.
    Zimmer, C.
    JOURNAL OF NEUROLOGY, 2006, 253 (08) : 1024 - 1029
  • [4] Profound midbrain atrophy in patients with Wilson’s disease and neurological symptoms?
    K. Strecker
    J. P. Schneider
    H. Barthel
    W. Hermann
    F. Wegner
    A. Wagner
    J. Schwarz
    O. Sabri
    C. Zimmer
    Journal of Neurology, 2006, 253 : 1024 - 1029
  • [5] Analysis of risk factors for neurological symptoms in patients with purely hepatic Wilson’s disease at diagnosis
    Sheng-Peng Diao
    Yang-Sha Zhuang
    Ye-Qing Huang
    Zhi-Hua Zhou
    Ai-Qun Liu
    Ming-Fan Hong
    BMC Neurology, 23
  • [6] Analysis of risk factors for neurological symptoms in patients with purely hepatic Wilson's disease at diagnosis
    Diao, Sheng-Peng
    Zhuang, Yang-Sha
    Huang, Ye-Qing
    Zhou, Zhi-Hua
    Liu, Ai-Qun
    Hong, Ming-Fan
    BMC NEUROLOGY, 2023, 23 (01)
  • [7] Clinical Spectrum of Symptoms and Treatment Response Behaviour in Longterm Treated Neurological Wilson Disease Patients: A Retrospective Analysis Over 10 Years
    Samadzadeh, Sara
    Albrecht, Philipp
    Hefter, Harald
    NEUROLOGY, 2020, 94 (15)
  • [8] To study the response of treatment in patients of neurological Wilson's disease
    Kumar, N.
    Joshi, D.
    MOVEMENT DISORDERS, 2014, 29 : S427 - S428
  • [9] Thrombocytopenia as a side effect of Trientene in the treatment of neurological symptoms of Wilson's disease
    Sabolek, M
    Weidenbach, M
    Storch, A
    Kraft, E
    AKTUELLE NEUROLOGIE, 2004, 31 (05) : 246 - 249
  • [10] Treatment of Wilson's disease with ammonium tetrathiomolyhdate: Experience in 3 cases with neurological symptoms
    De Fabregues, O.
    Palasi, A.
    Gamez, J.
    Callen, A.
    Hernandez-Vara, J.
    Duero, M.
    Auge, C.
    Alvarez-Sabin, J.
    MOVEMENT DISORDERS, 2010, 25 (07) : S233 - S234
12345